top of page

AvoMD partners with the SCCT to bring guidelines to the point-of-care

NEW YORK, August 3, 2022

AvoMD, a next-generation application-based clinical decision support platform, is working with the Society of Cardiovascular Computed Tomography (SCCT) to transform SCCT guidelines into actionable, instant guidance at the point-of-care. With support from Siemens Healthineers, the partnership will begin with the 2022 Coronary Artery Disease – Reporting and Data System (CAD-RADS 2.0).

CAD-RADS 2.0 is an expert consensus document originally created to standardize the reporting system for patients undergoing coronary CT angiography (CCTA) and to guide possible next steps in patient management. The recent update of the 2016 version was a collaboration among SCCT, American College of Cardiology (ACC), American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI).

AvoMD’s cloud-based solution,­ which will be accessible free of charge via websites, mobile apps and in electronic health records, supports and strengthens the ability of cardiologists and general physicians to provide critical services to patients of all ages. Provider organizations will have the ability to use AvoMD’s no-code content management tool to customize the offering for local needs.

Joanne Olson, chief executive officer of SCCT, commented, “SCCT is excited about the potential that a partnership with AvoMD provides. Making SCCT guidelines and expert consensus documents like CAD-RADS 2.0 instantly accessible in this way will help physicians administer higher quality care to their patients.”

AvoMD co-founder and CEO, Dr. Yair Saperstein commented: “We are thrilled to partner with the SCCT, the authority on cardiovascular CT imaging. Combining the SCCT’s clinical expertise with AvoMD’s decision support technology furthers our shared mission of equipping clinicians with the tools and expertise to provide high-quality, evidence-based care. We are excited to provide this offering to our growing base of health system customers and clinician users.”


About AvoMD

AvoMD is a no-code software platform that transforms clinical content – guidelines, algorithms, pathways, and checklists - into "virtual clinical consults" available instantly at the point-of-care on standalone web/mobile apps and in the EHR. Leading societies and health systems partner with AvoMD to transform authoritative clinical expertise into instant expert guidance at the bedside. Studies show that AvoMD improves outcomes, saves costs, and saves clinicians ~50% of their time in accessing and using information at the point-of-care.

Providers can access the software at these links: [mobile app] [web access] [EHR access] Learn more: Email:

About Siemens Healthineers AG

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at .

About the Society of Cardiovascular Computed Tomography

Founded in 2005, the Society of Cardiovascular Computed Tomography (SCCT) is the international professional society devoted to improving health outcomes through effective use of cardiovascular computed tomography (CCT). SCCT is a community of physicians, scientists and technologists from over 85 countries advocating for access, research, education and clinical excellence in the use of CCT. For more information, please visit

Learn more: Email:

bottom of page